A transgene construct was produced in which a modified human Angiopoietin 1 cDNA (COMP-Ang1) was separated from the CAG promoter by a loxP-blasticidineS cDNA-polyA-loxP sequence. The construct was injected into TT2 ES cells. A cre-expressing plasmid was introduced into the transfected ES cells and 2 clones demonstrated high levels of COMP-Ang1 expression. Transgenic mice were generated from clone 5. When crossed to a suitable cre-expressing line, the offspring will express the modified form of human angiopoietin 1. (J:147388)
Basic Information
(C57BL/6NCrlj x CBA/JNCrlj)F1
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count